Ecopipam Tablets to Study Tourette's Disorder in Children and Adolescents
Status:
Not yet recruiting
Trial end date:
2024-11-01
Target enrollment:
Participant gender:
Summary
This Phase 3 multicenter study evaluates the maintenance of efficacy, safety and tolerability
of ecopipam tablets in children, adolescents and adults in the treatment of Tourette's
Disorder (TD). The study includes an open-label period followed by double-blind,
placebo-controlled, randomized withdrawal period.